US OptionsDetailed Quotes
PTN240719C7500
- 0.05
- 0.000.00%
15min DelayClose Jun 6 12:48 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume1.75K Open Interest7.50Strike Price0.00Turnover8548.93%IV346.75%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0980Delta0.1172Gamma33.80Leverage Ratio-3.3446Theta0.0000Rho3.31Eff Leverage0.0000Vega
Palatin Technologies Stock Discussion
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...
Palatin Technologies, Inc. (NYSE American: PTN), a pioneering biopharmaceutical company, has recently made a significant stride in the treatment of obesity by gaining FDA clearance for its Investigational New Drug (IND) application. This clearance allows Palatin to proceed with a Phase 2 clinical study e...
Palatin Announces FDA Clearance of Ind Application for the Co-Administration of Bremelanotide With Tirzepatide (GLP-1) for the Treatment of Obesity
NEWS
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity
NEWS
Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024
In a significant development for millions suffering from Dry Eye Disease (DED), Palatin Technologies, Inc. recently unveiled the results of their Phase 3 PL9643 MELODY-1 clinical trial at the prestigious American Society of Cataract and Refractive Surgery (ASCRS) conference in 2024. The findings mark a promising advancement...
$Palatin Technologies(PTN.US)$ this company is huge opportunity it has massive funding with 6B USD it’s go to the top 100% sure.
my advice is buy
the $Palatin Technologies(PTN.US)$ will go to the point because it has 6B USD funding
now buy this is moment
No comment yet